| Literature DB >> 36263122 |
Min Li1, Wingyan Yun1,2, Guibin Wang1, Anqi Li1,2, Jing Gao1,2, Qingyong He1.
Abstract
The prevention and treatment of cardiovascular diseases (CVDs) have achieved initial results, but the number of CVDs patients will increase rapidly in the next 10 years. Atherosclerosis (AS) is a significant risk factor for CVDs. The impact of lifestyle and daily diet varies considerably between different countries and continents and has been shown to affect the development of various diseases such as diabetes and CVDs. Primary and secondary prevention using alternative supplements and methods to avoid or reduce the use of traditional pharmacological drugs have also become popular. One of the reasons for this is that pharmacological drugs with lipid-lowering, and blood pressure-lowering effects cause many side effects that may negatively impact the quality of life. Patients are now emphasizing reliance on lifestyle changes to reduce cardiovascular risks. Garlic is a medicinal and edible plant that has been used for a long time. In order to reveal garlic application in the prevention and treatment of AS, reviewing the latest domestic and international studies through searching databases. The result shows that the antiatherogenic role of garlic is eximious. And the mechanisms are mainly related to hypolipidemic, antioxidant, antithrombotic, inhibiting angiogenesis, protecting endothelial cells, anti-inflammatory, anti-apoptotic, inhibiting vascular smooth muscle proliferation, and regulating gut microbiota. The main signaling pathways involve AMPK/TLRs, Keap1/Nrf2, PI3K/AKT, PPARγ/LXRα, GEF-H1/RhoA/Rac, etc. The antiatherogenic actions and molecular mechanism of garlic were reviewed in this study to obtain a robust evidence basis for the clinical application and mechanistic study and provide a theoretical basis for further utilization of garlic.Entities:
Keywords: Allium sativum; atherosclerosis; endothelial dysfunction; garlic; inflammation; oxidative stress
Year: 2022 PMID: 36263122 PMCID: PMC9574545 DOI: 10.3389/fphar.2022.954938
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
FIGURE 1Summary of the literature search process.
FIGURE 2(A) Garlic plants. (B) Garlic bulbs. (C) Peeled garlic cloves.
FIGURE 3The representative sulfur compounds of garlic.
FIGURE 4Other compounds of garlic.
Major effects and targets of garlic in atherosclerosis.
| Effects | Materials or bioactive compound | Species/exposure subjects | Targets | Dose/concentration (route of administration) | Duration | Adverse effect | Reference |
|---|---|---|---|---|---|---|---|
| Hypolipidemic | Allicin | High-fat diet-induced Apo E−/− mices (6 w) and peritoneal macrophage | SR-A↓ | 10, 20 mg/kg/d (i.g., | 12 w | N |
|
| CD36↓ | |||||||
| JNK↓ | |||||||
| P38 MAPK↓ | |||||||
| NAC | High-fat diet-induced C57BL/6 mices (3—4 w) | SREBP-1c↓ | 1 g/L (i.g., | 4 w | N |
| |
| SEC | SREBP-2↓ | ||||||
| SPC | |||||||
| SAC | FFA mixture induced HepG2 cells | AMPK↑ | 0.5–10 mM | 24 h | N |
| |
| SREBP-1↓ | |||||||
| Allicin | Ox-LDL induced THP-1 macrophage-derived foam cells | ABCA1 ↑ | 2.5, 5, 10, 20 and 40 g/L | 3, 6, 12, 24, 48 h | N |
| |
| PPARγ/LXRα ↑ | |||||||
| Allicin | High-fat diet-induced Kunming mices (20 ± 2 g) | LCAT↑ | 1, 2, 3 mg/kg/d (i.g., | 10 days | N |
| |
| LPL↑ | |||||||
| HL↑ | |||||||
| HMGCR↓ | |||||||
| FGE | HepG2 | MTP↓ | 3, 6, 5 g/kg·bw (i.g., | 3, 6 h | N |
| |
| Caco-2 cells | |||||||
| Male SD rats (190–210 g) | |||||||
| GPE | Human aortic subendothelial intimal smooth muscle cells from men who died of myocardial infarction | ACAT↓ | allicin (3.58 mmol/L) and ajoene (0.184 mmol/L) | 24 h | N |
| |
| CEH↑ | |||||||
| DADS | High-fat diet-induced Wistar rats (200 ± 20 g) | SREBP-1c↓ | 15, 30, 60 mg/kg·bw (i.g., | 5 w | N |
| |
| PPAR-α↑ | |||||||
| Antioxidant | DADS | High-fat diet-induced Wistar rats (200 ± 20 g) | Keap1/Nrf2↑ | 15, 30, 60 mg/kg·bw (i.g., | 5 w | N |
|
| NQO1↑ | |||||||
| γ-GCSc↑ | |||||||
| SOD-1↑ | |||||||
| Allicin | H2O2 induced HUVECs | SIRT1↑ | 5 ng/ml | 24 h | N |
| |
| ROS↓ | |||||||
| PAI-1↓ | |||||||
| TSG | Combination of high-fat feeding, intraperitoneal injection of vitamin D3, and ovalbumin-induced inflammation in SD rats (200 ± 20 g) | MDA↓ | 0.6, 1.2, 2.4 g/kg/d (i.g., | 4 w | N |
| |
| SOD↑ | |||||||
| SAC | HUVECs and murine J774 macrophage cell line stimulated with ox-LDL | ROS↓ | 0,2.5,5,10,20 mM | 1, 2, 3 h | N |
| |
| NF-κB↓ | |||||||
| Allicin | High cholesterol diet-induced male New Zealand rabbits (1.30 ± 0.40 kg) | MDA↓ | 10 mg/kg/d (po, | 4 w | N |
| |
| SOD↑ | |||||||
| GSH↑ | |||||||
| Antithrombotic | TSG. | Combination of high-fat feeding, intraperitoneal injection of vitamin D3, and ovalbumin-induced inflammation in SD rats (200 ± 20 g) | TXB2↓ | 0.6, 1.2, 2.4 g/kg/d (i.g., | 4 w | N |
|
| 6-keto-PGF1α↑ | |||||||
| Fermented garlic | Hypercholesterolemic diet-induced SD rats (180–200 g) | α-granules↓ | 300 mg/kg/d (po, | 30 days | N |
| |
| Dense granules↓ | |||||||
| Garlic powder | Saline, collagen, and epinephrine induced SD rats (5 w) | VCAM-1↓ | 500 mg/kg·bw (i.g., | 7 days | N |
| |
| ICAM-1↓ | |||||||
| DATS | TNF-α stimulated HUVECs | JNK↓ | 50 or 100 μm | 30 min | N |
| |
| TF↓ | |||||||
| Inhibit angiogenesis | DATS | VEGF induced HUVECs | VEGF↓ | 5, 10, 20 μm | 24, 48, 72 h | N |
|
| VEGFR2↓ | |||||||
| Akt ↓ | |||||||
| ERK1/2 ↑ | |||||||
| Allicin | Type I collagen-induced rat aorta ring | VEGF↓ | 0.2, 0.5, 1 m | 6 days | N |
| |
| bFGF↓ | |||||||
| Allicin | Bovine aortic endothelial cells | VEGF↓ | 0.1, 0.2, 0.5, 1, 10 mm, | 24 h | N |
| |
| bFGF↓ | |||||||
| Akt ↓ | |||||||
| Endothelium Protection | Allicin capsule | Elderly myocardial infarction patients (57.86 ± 11.20 a) | ET-1↓ | 120 mg/d (po., | 1 a | N |
|
| CRP↓ | |||||||
| NO↑ | |||||||
| ASE | IL-1a induced HCAECs | ICAM-1↓ | 0.25–4.0 mg/ml | 4 days | N |
| |
| Monocytic U937 cell line | VCAM-1↓ | ||||||
| Allicin capsule | Patients with coronary heart disease combined with diabetes (61 ± 11 a) | NO↑ | 120 mg/d (po., | 90 days | N |
| |
| ICAM-1↓ | |||||||
| AGE | Endothelium-denuded aortic rings | eNOS↑ | 0.5% (w/v) | 10 min | N |
| |
| NO↑ | |||||||
| Allicin | Patients with angina pectoris (60.8 ± 10.7 a) | eNOS↑ | 60 mg/d (po., | 10 days | N |
| |
| NO↑ | |||||||
| DAT. | High glucose-induced HUVECs | MDA↓ | 25, 50, 100 mmol/L | 24 h | N |
| |
| ROS↓ | |||||||
| SOD↑ | |||||||
| GSH-Px↑ | |||||||
| Allicin | High-fat diet induced SD rats (220—250 g) | CaSR↓ | 20 mg/kg/d (i.g., | 14 days | N |
| |
| S1PC | TNF-α Induced HUVECs | GEF-H1/RhoA/Rac↓ | 75–300 μM | 10, 15, 20, 30, 40 min, 1, 3 or 24 h | N |
| |
| SAC | MLC kinase↓ | 300 μM | |||||
| SAMC | 300 μM | ||||||
| Anti-Inflammatory | AGE | CE-2 diet-induced ApoE-KO mices (5 w) | CRP↓ | Liquid AGE was mixed with CE-2 to make the solid content of AGE to 3% (po) | 12 w | N |
|
| TXB2↓ | |||||||
| TNF-α↓ | |||||||
| IRAK4↓ | |||||||
| AMPK↑ | |||||||
| AGE. | CE-2 diet-induced TSOD mices (4 w) | AMPK↑ | the CE-2 diet containing 2% (w/w) AGE (po) | 19 w | N |
| |
| TLR signal path↓ | |||||||
| Z-ajoene | L.P.S. induced RAW264.7 | STAT3↓ | 10 μL | 24 h | N |
| |
| COX2↓ | |||||||
| IL1β↓ | |||||||
| IL6↓ | |||||||
| IL12β↓ | |||||||
| IL10↑ | |||||||
| Single garlic oil | High-fat diet-induced Balb/C mices (38 ± 5 g) | CD4 t-cells↓ NF-κB↓ | 12.5, 25, 50 mg/kg·bw/d (po., | 4 w | N |
| |
| TNF-a↓ | |||||||
| IFN-g↓ | |||||||
| AGE | C57BL/6 J, Apo E−/− mices (6 w) | Arg1↑ | Standard diets with or with 3% AGE (po., | 17 w | N |
| |
| IL-10↑ | |||||||
| CD206↑ | |||||||
| HIF2α↑ | |||||||
| CD68↓ | |||||||
| HIF1α↓ | |||||||
| IL-10rαⓅ↑ | |||||||
| STAT3Ⓟ↑ | |||||||
| SHIP1↓ | |||||||
| Anti-apoptotic | Allicin | ox-LDL induced HUVECs | Caspase3↓ | 10–100 μM | 24 h | N |
|
| NADPH↓ | |||||||
| Allicin | LPS induced HUVECs | MMPs collapse↓ | 0–40 μg/ml | 24 h | N |
| |
| Cytochrome c↓ | |||||||
| Allicin | H2O2 induced HUVECs | Pro-Caspase-3 Protein↓ | 1, 10, 20, 40 μg/ml | 6, 12, 24 h | N |
| |
| PARP↓ | |||||||
| Bax↓ | |||||||
| SOD↑ | |||||||
| NO↑ | |||||||
| eNOS↑ | |||||||
| MDA↓ | |||||||
| Garlic oil | High cholesterol diet-induced Golden Syrian hamsters (145—170 g) | PI3K-Akt↑ | 2% cholesterol and 1% garlic oil (po., | 8 w | N |
| |
| TNF-α↓ | |||||||
| Fas↓ | |||||||
| caspase 8 | |||||||
| Bcl-2↑ | |||||||
| Bid↓ | |||||||
| Bax↓ | |||||||
| Inhibit smooth muscle proliferation | MATs | Insulin or PDGF induced VSMCs | PGGTase-I↓ | 50 mol/L | 24 h | N |
|
| AGE. | Cholesterol supplemented standard diet-induced New Zealand rabbits with carotid intima thickening (3–4 m) | PDGF↓ | 800 μl/kg·bw/d (po., | 6 w | N |
| |
| Regulating gut microbiota | Alliin | High-fat diet-induced C57BL/6J mices (8 w) | Lachnospiraceae↓ | 0.1 mg/ml (po., | 8 w | N |
|
| Ruminococcaceae↑ | |||||||
| Allicin | High-TMAO patients | Prausnitzii↑ | 0.89 mg/ml (po., | 1 w | N |
| |
| Akkermansia spp↑ |
FIGURE 5Mechanisms of the protective role of garlic in the treatment of atherosclerosis. ACAT, cholesterol acyltransferase; CEH, Cholesteryl ester hydrolase; LCAT, Lecithin cholesterol acyltransferase; LPL, Lipoprotein lipase; HL, Hepatic lipase; MTP, Microsomal triglyceride transfer protein; ABCA1, ATP Binding Cassette Subfamily A Member 1; HMGCR, Hydroxy-3-methyl glutaryl coenzyme A reductase; AMPK, AMP-activated protein kinase; FAS, Fatty acid synthase; SREBP, Sterol regulatory element-binding protein; TLR, Toll-like receptors; CRP, C-reaction protein; PPARγ, Peroxisome proliferator-activated receptor Gamma; LXRα, Liver X receptor α; IL-10, Interleukin-10; SHIP1, Src homology-2-containing inositol 5′-phosphatase 1; STAT3, Signal transducer and activator of transcription 3; Arg1, Arginase1; IRAK4, Interleukin-1 receptor-activated kinase 4; NF-κB, Nuclear factor kappa-B; IFN-g, Interferon gamma; NADPH, Nicotinamide adenine dinucleotide phosphate; PARP, Poly adenosine diphosphate-ribose polymerase; MMPs, Matrix metalloproteinases; TNF-α, Tumor necrosis factor-α; Fas, Fatty acid synthase; Bax, BCL2-Associated X; Bid, Recombinant Human BH3-Interacting Domain Death Agonist; Bcl-2, B-cell lymphoma-2; CaSR, Calcium-sensing receptor; eNOS, Endothelin nitric oxide synthase; ICAM-1, Intercellular cell adhesion molecule-1; VCAM-1, Vascular Cell Adhesion Molecule 1; ERK1/2, Extracellular regulated protein kinases; bFGF, Basic fibroblast growth factor; VEGF, Vascular endothelial growth factor; SIRT1, Sirtuin 1; ROS, Reactive oxygen species; PAI-1, Plasminogen Activator Inhibitor-1; GSH, Glutathione; SOD, Superoxide Dismutase; NQO1, NAD(P)H:quinone oxidoreductase 1; γ-GCSc, γ -glutamylcysteine synthetase antibody; SOD-1, Superoxide Dismutase 1; MDA, Malondialdehyde; TXB2, Thromboxane B2.